Key result
AV node ablation and His bundle pacing linked to a ~5% increase in reduced baseline LVEF.
Why the study?
Despite growing interest in physiological pacing, concerns remain regarding the long-term safety of permanent His bundle pacing after AV node ablation in patients with uncontrolled atrial arrhythmias.
Does permanent His bundle pacing and AV node ablation improve LVEF, NYHA class, and pacing parameters in patients with uncontrolled atrial tachyarrhythmias?
Observational (n=32)
Does permanent His bundle pacing and AV node ablation improve LVEF, NYHA class, and pacing parameters in patients with uncontrolled atrial tachyarrhythmias?
Absolute Event Rate: 50% vs 45%
p-value: p=<0.05
Permanent His bundle pacing combined with AV node ablation provides stable long-term pacing parameters and improves LVEF and functional class in patients with uncontrolled atrial tachyarrhythmias.
May support His bundle pacing plus AV node ablation in select atrial tachyarrhythmia patients; leaves open confirmation via randomized trials.
INTRODUCTION: In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long-term safety of permanent His bundle pacing (p-HBP) persist. Our current study aims to evaluate the long-term outcomes of patients who underwent AV node ablation and p-HBP, focusing on left ventricular ejection fraction (LVEF), NYHA class, readmissions, and pacing parameters. METHODS: This descriptive observational study involved patients with uncontrolled permanent atrial arrhythmias who were eligible for heart rate (HR) control (between January 2019 and July 2020) and underwent p-HBP and AV node ablation, followed during a near 4-year period. RESULTS: We conducted a long-term follow-up study with a median duration of 47 months on 32 patients who received p-HBP followed by AV node ablation. The average age was 77 years, predominantly female (65.6%), with a high prevalence of hypertension (90.6%). The main indications for ablation were uncontrolled AF (59.4%) and atypical atrial flutter (37.5%). At baseline, the median LVEF was 60%. Notably, LVEF improved significantly from 45% to 50% in those with reduced baseline function (p < 0.05). NYHA class improvements were also observed over time. The His thresholds remained similar during long-term follow-up, being 1.25 V at 0.4 ms (1.25-2.4 V at 0.4 ms) before AV node ablation and 1.30 V at 0.4 ms (0.75-2.25 V at 0.4 ms), p = 0.89, at long-term follow-up. The impedances remained stable. No complications related to the pacemaker occurred. Number of medications per patient for HR control significantly decreased from 1.6 to 0.37 (p < 0.05), while hospital admissions for tachyarrhythmias dropped markedly. There was one death during the follow-up due to cancer, but conclusions regarding mortality are limited by the small sample size. CONCLUSIONS: AV node ablation and p-HBP significantly improve functional class and LVEF, with benefits maintained over time. Patients experience fewer emergency visits and reduced HR medication. Pacing parameters remained stable during long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Salas et al. (2025) conducted an observational in Uncontrolled permanent atrial arrhythmias (n=32). AV node ablation and permanent His bundle pacing vs. Baseline (pre-ablation) was evaluated on Left ventricular ejection fraction (LVEF) in patients with reduced baseline function (p=<0.05). AV node ablation and permanent His bundle pacing significantly improved LVEF from 45% to 50% in patients with reduced baseline function (p < 0.05) over a median follow-up of 47 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: